These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 12009355)
1. Effect of paracentesis of ascitic fluids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Levin I; Almog B; Avni A; Baram A; Lessing JB; Gamzu R Fertil Steril; 2002 May; 77(5):986-8. PubMed ID: 12009355 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Abramov Y; Barak V; Nisman B; Schenker JG Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600 [TBL] [Abstract][Full Text] [Related]
3. Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation. Maslovitz S; Jaffa A; Eytan O; Wolman I; Many A; Lessing JB; Gamzu R Obstet Gynecol; 2004 Aug; 104(2):321-6. PubMed ID: 15292006 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome. Barak V; Elchalal U; Edelstein M; Kalickman I; Lewin A; Abramov Y Fertil Steril; 2004 Aug; 82(2):415-20. PubMed ID: 15302292 [TBL] [Abstract][Full Text] [Related]
5. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome. Fluker MR; Copeland JE; Yuzpe AA Fertil Steril; 2000 Apr; 73(4):821-4. PubMed ID: 10731547 [TBL] [Abstract][Full Text] [Related]
6. [Severe ovarian hyperstimulation syndrome treatment by decompressive paracentesis and self-transfusion of ascitis fluid]. Kably Ambe A; Ruiz Anguas J; Sánchez de León A Ginecol Obstet Mex; 2006 Jun; 74(6):291-9. PubMed ID: 16970114 [TBL] [Abstract][Full Text] [Related]
7. Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report. Abramov Y; Fatum M; Abrahamov D; Schenker JG Fertil Steril; 2001 Jun; 75(6):1228-30. PubMed ID: 11384657 [TBL] [Abstract][Full Text] [Related]
8. Levels of soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 are increased in women with ovarian hyperstimulation syndrome. Daniel Y; Geva E; Amit A; Baram A; Englander T; Kupferminc MJ; Fait G; Lessing JB Fertil Steril; 1999 May; 71(5):896-901. PubMed ID: 10231053 [TBL] [Abstract][Full Text] [Related]
9. [Ascitic fluid puncture in the treatment of severe forms of ovarian hyperstimulation syndrome]. Machac S; Dostál J; Oborná I; Zahradnícková V; Brezinová J; Labanová M; Kudela M Ceska Gynekol; 2001 Sep; 66(5):333-6. PubMed ID: 11732230 [TBL] [Abstract][Full Text] [Related]
11. Continuous abdominal paracentesis for management of late type severe ovarian hyperstimulation syndrome. Chan CC; Yin CS; Lan SC; Chen IC; Wu GJ J Chin Med Assoc; 2004 Apr; 67(4):197-9. PubMed ID: 15244020 [TBL] [Abstract][Full Text] [Related]
12. Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome. Chen CD; Yang JH; Chao KH; Chen SU; Ho HN; Yang YS Hum Reprod; 1998 Aug; 13(8):2077-81. PubMed ID: 9756272 [TBL] [Abstract][Full Text] [Related]
13. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis. Smith LP; Hacker MR; Alper MM Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762 [TBL] [Abstract][Full Text] [Related]
14. Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Abramov Y; Schenker JG; Lewin A; Kafka I; Jaffe H; Barak V Fertil Steril; 2001 Jul; 76(1):51-7. PubMed ID: 11438319 [TBL] [Abstract][Full Text] [Related]
15. [Integral treatment of severe ovarian hyperstimulation syndrome by means of autotransfusion of ascitic fluid and intravenous infusion of albumin]. Barrón Vallejo J; Pereyra Quiñones R; Esparza Iturbide JA; Kably Ambe A Ginecol Obstet Mex; 1998 Aug; 66():347-9. PubMed ID: 9745198 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management. Delbaere A; Bergmann PJ; Gervy-Decoster C; Staroukine M; Englert Y Fertil Steril; 1994 Oct; 62(4):731-7. PubMed ID: 7926081 [TBL] [Abstract][Full Text] [Related]
17. Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome. Aboulghar MA; Mansour RT; Serour GI; Riad R; Ramzi AM Fertil Steril; 1992 Nov; 58(5):1056-9. PubMed ID: 1426358 [TBL] [Abstract][Full Text] [Related]
18. Predictors of Paracentesis in Women with Severe Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study. Nouri K; Ott J; Lenart C; Walch K; Promberger R; Tempfer CB Gynecol Obstet Invest; 2016; 81(6):504-511. PubMed ID: 27399220 [TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997 [TBL] [Abstract][Full Text] [Related]
20. Transvaginal drainage of ascites as an alternative to abdominal paracentesis in patients with severe ovarian hyperstimulation syndrome, obesity, and generalized edema. Raziel A; Friedler S; Schachter M; Strassburger D; Bukovsky I; Ron-El R Fertil Steril; 1998 Apr; 69(4):780-3. PubMed ID: 9548173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]